Forecast: Import of Medicaments for Therapeutic, Prophylactic Use, in Dosage to Angola

The import of medicaments for therapeutic and prophylactic use in dosage to Angola has shown varying trends over the past decade. Between 2013 and 2023, the value fluctuated significantly with periods of notable increase and decrease. For instance, there were substantial increases in 2014 (21.19%) and 2018 (23.32%) contrasted by declines in 2015 (-18.26%) and 2016 (-10.4%). In 2023, the import value stood at 324.08 million USD, a 3.26% rise from the previous year.

Over the last two years, the import value experienced moderate growth, with a 3.64% increase in 2021 and a slight decrease of -1.48% in 2022. The average variation per year (CAGR) over the past five years was 2.46%, indicating a relatively stable but slow growth pattern. Looking forward, the forecast predicts a continued growth trend with an expected annual average increase (CAGR) of 2.14% over the next five years, reaching 372.91 million USD by 2028.

Future trends to watch for include potential shifts in Angola's healthcare policies, economic conditions affecting import capacity, and global pharmaceutical supply chain dynamics. Monitoring these factors can offer insights into the stability and growth of medicament imports.